Glenmede Trust’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-476
| Closed | -$7K | – | 1408 |
|
|
2020
Q3 | $7K | Sell |
476
-340
| -42% | -$7.13K | ﹤0.01% | 1985 |
|
|
2020
Q2 | $16K | Buy |
816
+678
| +491% | +$12.2K | ﹤0.01% | 1666 |
|
|
2020
Q1 | $5K | Hold |
138
| – | – | ﹤0.01% | 2666 |
|
|
2019
Q4 | $5K | Hold |
138
| – | – | ﹤0.01% | 2666 |
|
|
2019
Q3 | $6 | Sell |
138
-16
| -10% | -$744 | ﹤0.01% | 2554 |
|
|
2019
Q2 | $8 | Sell |
154
-2,507
| -94% | -$147K | ﹤0.01% | 2458 |
|
|
2019
Q1 | $183 | Buy |
2,661
+2,111
| +384% | +$142K | ﹤0.01% | 1205 |
|
|
2018
Q4 | $32 | Buy |
+550
| New | +$47.5K | ﹤0.01% | 1778 |
|
|
2018
Q3 | – | Sell |
-467
| Closed | -$59K | – | 1508 |
|
|
2018
Q2 | $59K | Buy |
+467
| New | +$56.8K | ﹤0.01% | 1390 |
|
|
2017
Q4 | – | Sell |
-600
| Closed | -$59K | – | 2683 |
|
|
2017
Q3 | $59K | Hold |
600
| – | – | ﹤0.01% | 1584 |
|
|
2017
Q2 | $69K | Hold |
600
| – | – | ﹤0.01% | 1487 |
|
|
2017
Q1 | $69K | Hold |
600
| – | – | ﹤0.01% | 1487 |
|
|
2016
Q4 | $72K | Hold |
600
| – | – | ﹤0.01% | 1489 |
|
|
2016
Q3 | $67K | Hold |
600
| – | – | ﹤0.01% | 1508 |
|
|
2016
Q2 | $74K | Buy |
600
+549
| +1,076% | +$66.3K | ﹤0.01% | 1436 |
|
|
2016
Q1 | $5K | Sell |
51
-51
| -50% | -$5.3K | ﹤0.01% | 2197 |
|
|
2015
Q4 | $11K | Buy |
+102
| New | +$11.7K | ﹤0.01% | 2038 |
|
|
2014
Q4 | – | Sell |
-90
| Closed | -$13K | – | 2537 |
|
|
2014
Q3 | $13K | Buy |
90
+11
| +14% | +$1.7K | ﹤0.01% | 2064 |
|
|
2014
Q2 | $13K | Sell |
79
-20
| -20% | -$3.56K | ﹤0.01% | 1989 |
|
|
2014
Q1 | $19K | Sell |
99
-7
| -7% | -$1.32K | ﹤0.01% | 1894 |
|
|
2013
Q4 | $20K | Buy |
106
+3
| +3% | +$558 | ﹤0.01% | 1842 |
|
|
2013
Q3 | $17K | Sell |
103
-150
| -59% | -$23.3K | ﹤0.01% | 1827 |
|
|
2013
Q2 | $38K | Buy |
+253
| New | +$35.8K | ﹤0.01% | 1583 |
|
Other funds holding CLB
AI
FAM
AC
